TheEdgeResearch
Home / Stocks / FOGCF

Avisa Diagnostics Inc. (FOGCF)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$97,176
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
1.28
52-Wk Range
0.000001-0.00001
CEO
David S. Joseph
Country
US
Currency
USD

Avisa Diagnostics Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Santa Fe, NM, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $97,176. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -257.6%. Its beta of 1.28 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.35
Price / Book
-0.00
EV / EBITDA
-0.21
Gross margin
46.5%
Operating margin
-324.2%
Net margin
-257.6%
Return on equity
—
Debt / equity
-0.29
Current ratio
0.23
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2021-02-17
Headquarters
Santa Fe, NM, US
About Avisa Diagnostics Inc.

Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa Fe, New Mexico, is dedicated to developing the Avisa BreathTest. This innovative drug/device biomarker technology platform is designed for the ultra-rapid identification of virulent bacterial pathogens and the subsequent monitoring of bacterial load. The system works by analyzing a patient's breath after they have inhaled or ingested Avisa's proprietary drug substrates. The company has already established clinical proof-of-concept through trials in conditions such as cystic fibrosis, tuberculosis, and community-acquired pneumonia, and is now concentrating on pivotal trials for Post-COVID-19 bronchiectasis and ventilator-associated pneumonia.

Comparable companies

Avisa Diagnostics Inc. is most often compared with the following Healthcare names:

BJTRFBPMUFCALZFELTPMNFSFSWDCFTRXPFTSUSFXVIPFYIHCF
More research on FOGCF
FOGCF technical analysis FOGCF TheEdge Score Compare against peers
Open full interactive analysis & DCF →